H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
RIEG2 |
|
Rieger syndrome 2
|
|
|
0.674 |
0.462 |
DEL11P13 |
|
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome
|
|
|
0.716 |
0.538 |
DEL11P13 |
|
Chromosome 11p13 deletion syndrome, distal
|
|
|
0.861 |
0.231 |
WNT10B |
O00744
|
Wnt family member 10B
|
Signaling
|
3.6E-04 |
0.576 |
0.654 |
SDHD |
O14521
|
succinate dehydrogenase complex subunit D
|
Transporter
|
0.34 |
0.472 |
0.885 |
KIF1B |
O60333
|
kinesin family member 1B
|
Cellular structure
|
1.00 |
0.516 |
0.808 |
TMEM127 |
O75204
|
transmembrane protein 127
|
|
1.3E-02 |
0.638 |
0.615 |
SIX6 |
O95475
|
SIX homeobox 6
|
Transcription factor
|
0.52 |
0.588 |
0.654 |
ALDH1A1 |
P00352
|
aldehyde dehydrogenase 1 family member A1
|
Enzyme
|
0.95 |
0.460 |
0.846 |
NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |
CAT |
P04040
|
catalase
|
Enzyme
|
1.6E-10 |
0.359 |
0.962 |
APOB |
P04114
|
apolipoprotein B
|
|
1.9E-16 |
0.453 |
0.808 |
RET |
P07949
|
ret proto-oncogene
|
Kinase
|
1.00 |
0.392 |
0.885 |
FH |
P07954
|
fumarate hydratase
|
Enzyme
|
8.8E-02 |
0.489 |
0.846 |
FGF2 |
P09038
|
fibroblast growth factor 2
|
Signaling
|
1.8E-02 |
0.383 |
0.923 |
CXCL8 |
P10145
|
C-X-C motif chemokine ligand 8
|
Signaling
|
2.7E-04 |
0.310 |
0.962 |
CCL3 |
P10147
|
C-C motif chemokine ligand 3
|
Signaling
|
0.35 |
0.460 |
0.885 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
VEGFA |
P15692
|
vascular endothelial growth factor A
|
Signaling
|
2.4E-05 |
0.266 |
0.923 |
CHN1 |
P15882
|
chimerin 1
|
|
3.1E-02 |
0.573 |
0.615 |
ATP2A2 |
P16615
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
|
Transporter
|
1.00 |
0.529 |
0.808 |